HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Kentaro Yamazaki Selected Research
Kentaro Yamazaki Research Topics
Disease
83
Colorectal Neoplasms (Colorectal Cancer)
10/2022 - 07/2006
50
Neoplasms (Cancer)
10/2022 - 12/2005
17
Neutropenia
12/2021 - 07/2006
16
Stomach Neoplasms (Stomach Cancer)
06/2020 - 02/2007
10
Neoplasm Metastasis (Metastasis)
09/2020 - 12/2005
9
Disease Progression
10/2021 - 02/2007
8
Febrile Neutropenia
12/2021 - 04/2008
8
Colonic Neoplasms (Colon Cancer)
01/2021 - 04/2013
7
Diarrhea
07/2020 - 07/2006
7
Adenocarcinoma
06/2020 - 01/2009
6
Pancreatic Neoplasms (Pancreatic Cancer)
08/2022 - 01/2008
6
Hypertension (High Blood Pressure)
01/2018 - 12/2009
6
Nausea
01/2017 - 01/2008
5
Ascites
06/2020 - 10/2006
4
Hemorrhage
04/2021 - 12/2009
4
Esophageal Neoplasms (Esophageal Cancer)
10/2019 - 04/2008
4
Proteinuria
01/2018 - 11/2009
4
Fatigue
05/2015 - 04/2012
4
Anorexia
03/2015 - 01/2008
2
Lymphatic Metastasis
04/2022 - 12/2005
2
Peripheral Nervous System Diseases (PNS Diseases)
07/2021 - 04/2013
2
Thrombosis (Thrombus)
04/2021 - 12/2009
2
Rectal Neoplasms (Rectal Cancer)
01/2021 - 03/2015
2
Gastrointestinal Neoplasms (Gastrointestinal Cancer)
12/2020 - 10/2011
2
Esophageal Squamous Cell Carcinoma
10/2018 - 05/2018
2
Esophageal Fistula
05/2018 - 08/2011
2
Leukopenia
01/2017 - 05/2015
2
Hand-Foot Syndrome
01/2017 - 11/2014
2
Carcinoma (Carcinomatosis)
10/2015 - 01/2002
2
Thrombocytopenia (Thrombopenia)
06/2015 - 11/2009
2
Hypoxia (Hypoxemia)
02/2013 - 01/2002
2
Squamous Cell Carcinoma of Head and Neck
01/2012 - 12/2011
2
Glioma (Gliomas)
04/2011 - 03/2011
1
Cancer Pain
01/2022
1
Mood Disorders (Mood Disorder)
01/2022
1
Biliary Tract Neoplasms (Biliary Tract Cancer)
10/2021
1
Gallbladder Neoplasms (Gallbladder Cancer)
10/2021
1
Cardiovascular Diseases (Cardiovascular Disease)
04/2021
1
Venous Thrombosis (Deep-Vein Thrombosis)
04/2021
Drug/Important Bio-Agent (IBA)
37
Irinotecan (Camptosar)
FDA Link
Generic
12/2021 - 07/2006
31
Oxaliplatin (Eloxatin)
FDA Link
Generic
12/2021 - 09/2007
28
Fluorouracil (Carac)
FDA Link
Generic
09/2020 - 12/2005
23
Bevacizumab (Avastin)
FDA Link
12/2021 - 08/2007
17
trifluridine tipiracil drug combination
IBA
07/2021 - 10/2012
13
Biomarkers (Surrogate Marker)
IBA
04/2022 - 02/2011
12
Cisplatin (Platino)
FDA Link
Generic
10/2021 - 12/2005
12
Leucovorin (Folinic Acid)
FDA Link
09/2020 - 07/2006
11
regorafenib
IBA
04/2021 - 06/2015
10
Panitumumab (Vectibix)
FDA Link
07/2021 - 05/2008
10
Cetuximab (Erbitux)
FDA Link
06/2020 - 05/2008
8
Ramucirumab
IBA
11/2021 - 05/2015
8
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
10/2021 - 01/2002
8
Monoclonal Antibodies
IBA
06/2021 - 08/2007
6
Circulating Tumor DNA
IBA
04/2022 - 12/2016
5
Gemcitabine
FDA Link
10/2021 - 12/2005
5
ErbB Receptors (EGF Receptor)
IBA
07/2021 - 05/2008
4
Capecitabine (Xeloda)
FDA Link
12/2021 - 11/2014
4
DNA (Deoxyribonucleic Acid)
IBA
10/2020 - 09/2002
4
Paclitaxel (Taxol)
FDA Link
Generic
06/2020 - 12/2005
4
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
01/2017 - 02/2013
4
S-1 plus cisplatin
IBA
02/2013 - 12/2008
3
Platinum
IBA
10/2020 - 04/2008
3
aflibercept
IBA
11/2019 - 08/2013
3
Antibodies
IBA
01/2019 - 12/2012
3
Docetaxel (Taxotere)
FDA Link
12/2018 - 04/2008
3
Pharmaceutical Preparations
IBA
01/2017 - 01/2009
3
Codon (Codons)
IBA
09/2013 - 03/2011
3
Epidermal Growth Factor (EGF)
IBA
12/2012 - 04/2012
2
Immune Checkpoint Inhibitors
IBA
01/2022 - 11/2016
2
Vascular Endothelial Growth Factor D
IBA
10/2021 - 10/2020
2
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
01/2021 - 12/2018
2
Proteins (Proteins, Gene)
FDA Link
11/2019 - 12/2018
2
Serum Albumin
IBA
10/2019 - 12/2018
2
Alanine Transaminase (SGPT)
IBA
01/2017 - 04/2013
2
Bilirubin
IBA
01/2017 - 04/2013
2
Paraffin
IBA
01/2016 - 02/2011
2
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
08/2015 - 05/2015
2
PPAR gamma
IBA
09/2014 - 06/2014
2
efatutazone
IBA
09/2014 - 06/2014
2
cediranib (AZD2171)
IBA
08/2012 - 11/2009
2
Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))
IBA
04/2011 - 03/2011
1
Notch Receptors
IBA
10/2022
1
N-acetyltalosaminuronic acid (NAT)
IBA
08/2022
1
pembrolizumab
IBA
01/2022
1
Volatile Oils (Essential Oils)
IBA
01/2022
1
4-boronic acid benzophenone
IBA
10/2021
Therapy/Procedure
55
Drug Therapy (Chemotherapy)
10/2022 - 12/2005
46
Therapeutics
01/2022 - 07/2006
9
Chemoradiotherapy
10/2019 - 01/2008
4
Combination Drug Therapy (Combination Chemotherapy)
04/2012 - 06/2010
3
Radiotherapy
01/2018 - 12/2005
2
Neoadjuvant Therapy
08/2022 - 01/2022
2
Lymph Node Excision (Lymph Node Dissection)
04/2022 - 03/2015
2
Hepatectomy
01/2020 - 03/2018
2
Total Parenteral Nutrition
10/2019 - 02/2007
1
Pancreatectomy
08/2022
1
Aftercare (After-Treatment)
04/2022
1
Complementary Therapies (Alternative Medicine)
01/2022
1
Aromatherapy
01/2022
1
Time-to-Treatment
10/2021